Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 192

1.

Epicardial adipose tissue adiponectin expression is related to intracoronary adiponectin levels.

Iacobellis G, di Gioia CR, Cotesta D, Petramala L, Travaglini C, De Santis V, Vitale D, Tritapepe L, Letizia C.

Horm Metab Res. 2009 Mar;41(3):227-31. doi: 10.1055/s-0028-1100412. Erratum in: Horm Metab Res. 2009 Mar;41(3):259. di Gioia, C R Tiziana [corrected to di Gioia, Cira Rosaria Tiziana].

PMID:
19003726
2.

Epicardial adipose tissue and intracoronary adrenomedullin levels in coronary artery disease.

Iacobellis G, di Gioia CR, Di Vito M, Petramala L, Cotesta D, De Santis V, Vitale D, Tritapepe L, Letizia C.

Horm Metab Res. 2009 Dec;41(12):855-60. doi: 10.1055/s-0029-1231081.

PMID:
19623513
3.

Adiponectin expression in human epicardial adipose tissue in vivo is lower in patients with coronary artery disease.

Iacobellis G, Pistilli D, Gucciardo M, Leonetti F, Miraldi F, Brancaccio G, Gallo P, di Gioia CR.

Cytokine. 2005 Mar 21;29(6):251-5.

PMID:
15749025
4.

Adiponectin produced in coronary circulation regulates coronary flow reserve in nondiabetic patients with angiographically normal coronary arteries.

Date H, Imamura T, Ideguchi T, Kawagoe J, Sumi T, Masuyama H, Onitsuka H, Ishikawa T, Nagoshi T, Eto T.

Clin Cardiol. 2006 May;29(5):211-4.

5.

[Gender differences in adiponectin and leptin expression in epicardial and subcutaneous adipose tissue. Findings in patients undergoing cardiac surgery].

Iglesias MJ, Eiras S, Piñeiro R, López-Otero D, Gallego R, Fernández AL, Lago F, González-Juanatey JR.

Rev Esp Cardiol. 2006 Dec;59(12):1252-60. Spanish.

6.

Adipocytokines and proinflammatory mediators from abdominal and epicardial adipose tissue in patients with coronary artery disease.

Cheng KH, Chu CS, Lee KT, Lin TH, Hsieh CC, Chiu CC, Voon WC, Sheu SH, Lai WT.

Int J Obes (Lond). 2008 Feb;32(2):268-74.

PMID:
17878891
7.

Extension of coronary artery disease is associated with increased IL-6 and decreased adiponectin gene expression in epicardial adipose tissue.

Eiras S, Teijeira-Fernández E, Shamagian LG, Fernandez AL, Vazquez-Boquete A, Gonzalez-Juanatey JR.

Cytokine. 2008 Aug;43(2):174-80. doi: 10.1016/j.cyto.2008.05.006.

PMID:
18562207
8.

Roles of human epicardial adipose tissue in coronary artery atherosclerosis.

Chen X, Jiao Z, Wang L, Sun Z, Wei Y, Wang X, Xia D.

J Huazhong Univ Sci Technolog Med Sci. 2010 Oct;30(5):589-93. doi: 10.1007/s11596-010-0547-9.

PMID:
21063839
9.

Human epicardial adipose tissue expresses a pathogenic profile of adipocytokines in patients with cardiovascular disease.

Baker AR, Silva NF, Quinn DW, Harte AL, Pagano D, Bonser RS, Kumar S, McTernan PG.

Cardiovasc Diabetol. 2006 Jan 13;5:1.

10.

Enhanced inflammation in epicardial fat in patients with coronary artery disease.

Hirata Y, Kurobe H, Akaike M, Chikugo F, Hori T, Bando Y, Nishio C, Higashida M, Nakaya Y, Kitagawa T, Sata M.

Int Heart J. 2011;52(3):139-42.

11.

Adipose tissue gene expression of adiponectin, tumor necrosis factor-α and leptin in metabolic syndrome patients with coronary artery disease.

Gormez S, Demirkan A, Atalar F, Caynak B, Erdim R, Sozer V, Gunay D, Akpinar B, Ozbek U, Buyukdevrim AS.

Intern Med. 2011;50(8):805-10.

12.

Adiponectin--its potential to predict and prevent coronary artery disease.

Skrabal CA, Czaja J, Honz K, Emini R, Hannekum A, Friedl R.

Thorac Cardiovasc Surg. 2011 Jun;59(4):201-6. doi: 10.1055/s-0030-1250211.

PMID:
21416461
13.

Effects of pravastatin and rosuvastatin on the generation of adiponectin in the visceral adipose tissue in patients with coronary artery disease.

Yokoyama H, Saito S, Daitoku K, Fukuda I, Higuma T, Hanada H, Osanai T, Okumura K.

Fundam Clin Pharmacol. 2011 Jun;25(3):378-87. doi: 10.1111/j.1472-8206.2010.00847.x.

PMID:
20608995
14.

Decreased adiponectin and increased inflammation expression in epicardial adipose tissue in coronary artery disease.

Zhou Y, Wei Y, Wang L, Wang X, Du X, Sun Z, Dong N, Chen X.

Cardiovasc Diabetol. 2011 Jan 12;10:2. doi: 10.1186/1475-2840-10-2.

15.

Human epicardial adipose tissue is a source of inflammatory mediators.

Mazurek T, Zhang L, Zalewski A, Mannion JD, Diehl JT, Arafat H, Sarov-Blat L, O'Brien S, Keiper EA, Johnson AG, Martin J, Goldstein BJ, Shi Y.

Circulation. 2003 Nov 18;108(20):2460-6.

16.

Diabetes mellitus has an additional effect on coronary artery disease.

Chan KC, Chou HH, Wu DJ, Wu YL, Huang CN.

Jpn Heart J. 2004 Nov;45(6):921-7.

17.

High molecular weight adiponectin as a predictor of long-term clinical outcome in patients with coronary artery disease.

Inoue T, Kotooka N, Morooka T, Komoda H, Uchida T, Aso Y, Inukai T, Okuno T, Node K.

Am J Cardiol. 2007 Aug 15;100(4):569-74.

PMID:
17697807
18.

Coronary artery disease is associated with higher epicardial retinol-binding protein 4 (RBP4) and lower glucose transporter (GLUT) 4 levels in epicardial and subcutaneous adipose tissue.

Salgado-Somoza A, Teijeira-Fernández E, Rubio J, Couso E, González-Juanatey JR, Eiras S.

Clin Endocrinol (Oxf). 2012 Jan;76(1):51-8. doi: 10.1111/j.1365-2265.2011.04140.x.

PMID:
21645024
19.

Adiponectin gene expression and adipocyte diameter: a comparison between epicardial and subcutaneous adipose tissue in men.

Bambace C, Telesca M, Zoico E, Sepe A, Olioso D, Rossi A, Corzato F, Di Francesco V, Mazzucco A, Santini F, Zamboni M.

Cardiovasc Pathol. 2011 Sep-Oct;20(5):e153-6. doi: 10.1016/j.carpath.2010.07.005.

PMID:
20829073
20.

Epicardial adipose tissue expression of adiponectin is lower in patients with hypertension.

Teijeira-Fernandez E, Eiras S, Grigorian-Shamagian L, Fernandez A, Adrio B, Gonzalez-Juanatey JR.

J Hum Hypertens. 2008 Dec;22(12):856-63. doi: 10.1038/jhh.2008.75.

PMID:
18650840
Items per page

Supplemental Content

Support Center